| Literature DB >> 35427359 |
Ching-Ju Chiu1, Lin-Chun Hua1, Chieh-Ying Chou1,2, Jung-Hsien Chiang3.
Abstract
PURPOSE: This study assessed robot-enhanced healthcare in practical settings for the purpose of community diabetes care.Entities:
Mesh:
Year: 2022 PMID: 35427359 PMCID: PMC9012373 DOI: 10.1371/journal.pone.0265384
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the diabetic participants.
| Variable | ||
|---|---|---|
|
|
| |
|
| ||
| Sex | ||
| Male | 15(50.0) | 6(50.0) |
| Female | 15(50.0) | 6(50.0) |
| Age (range 45–85 years) | 69.2±9.690 | 65.75±9.640 |
| 45–64 | 8(26.7) | 5(41.7) |
| 65–74 | 13(43.3) | 4(33.3) |
| 75 years and over | 9(30.0) | 3(25) |
| Place of Residence | ||
| Urban area | 20(66.7) | |
| Countryside | 10(33.3) | |
| Education Level | ||
| Primary School and below | 11(36.7) | 2(16.7) |
| Secondary and High School | 13(43.3) | 6(50.0) |
| University or above | 6(20.0) | 4(33.3) |
|
| ||
| History of diabetes mellitus | ||
| Less than 5 years | 8(26.7) | 4(33.3) |
| 6–10 years | 7(23.3) | 2(16.7) |
| 10+ years | 15(50.0) | 6(50.0) |
| History of other diseases | ||
| Hypertension | 21(70.0) | 8(66.7) |
| Hyperlipidemia | 10(33.3) | 3(25) |
| Cardiac disease | 9(30.0) | 5(41.7) |
| Arthritis | 5(16.7) | 3(25) |
| Renal Disease | 2(6.7) | |
| Chronic Liver Disease | 1(3.3) | |
|
| ||
| Internet experience | ||
| No experience | 15(50.0) | 4(33.3) |
| Less than 5 years of experience | 5(16.7) | 3(25) |
| 6 years or more | 10(33.3) | 5(41.7) |
| Experience using mobile applications | ||
| No experience at all | 13(43.3) | 3(25) |
| Have used, but do not know how to download applications (apps) | 10(33.3) | 8(66.7) |
| Can download apps and operate them by oneself | 7(22.3) | 1(8.3) |
| Experience of using robots | ||
| Never heard of or used it at all | 12(40.0) | 5(41.7) |
| Have heard of or seen others use it but have not used it myself | 16(53.3) | 6(50.0) |
| Have experience with using robots | 2(6.7) | 1(8.3) |
Characteristics of pharmacist respondents (n = 10) .
| Variable | |
|---|---|
|
| |
| Male | 9(90.0) |
| Female | 1(10.0) |
|
| 49.6±14.057 |
| 28–45 | 5(50.0) |
| 46–64 | 4(40.0) |
| 65 years old and above | 1(10.0) |
|
| 17.80±13.57 |
| 1–10 years | 5(50.0) |
| 10–30 years | 1(10.0) |
| 30+ years | 4(40.0) |
|
| |
| Urban areas | 9(90.0) |
| Countryside | 1(10.0) |
a Urban areas are defined as urbanized areas: those with a population density of 300 or more people per square kilometers [21].
Summary of satisfaction ratings a-b.
| Questions on the Satisfaction Questionnaire | M(SD) | Negative judgement | Neutral judgement | Positive judgement |
|---|---|---|---|---|
|
| ||||
| Pleasant | 4.00(.98) | 4(13.3) | 2(6.7) | 24(80.0) |
| Novelty of access to technology | 4.03(.96) | 3(10.0) | 4(13.3) | 23(76.7) |
| Smooth and easy | 4.00(1.05) | 4(13.3) | 1(3.3) | 25(83.3) |
| Average score |
| |||
|
| ||||
| Getting more information about diabetes | 4.10(.96) | 3(10.0) | 3(10.0) | 24(80.0) |
| Can share with friends and family | 4.07(.91) | 3(10.0) | 2(6.7) | 25(83.3) |
| Average score |
| |||
|
| ||||
| Facilitated my communication with pharmacists in the community | 3.97(.93) | 2(6.7) | 7(23.3) | 21(70.0) |
| Having the opportunity to meet people with diabetes and share experiences | 4.27(.69) | 1(3.3) | 1(3.3) | 28(93.3) |
| Average score |
| |||
|
| ||||
| Functionality meets expectations | 3.80(1.16) | 5(16.6) | 5(16.7) | 20(66.7) |
| Average score |
| |||
|
| ||||
| The information is reliable. | 4.07(.69) | 0 | 6(25.0) | 24(75.0) |
| I can clearly understand the message being delivered. | 4.17(.75) | 1(3.3) | 3(10.0) | 26(86.7) |
| Average score |
| |||
Summary of paired t-tests for diabetic patients on pretest-posttest changes in interactions with health care robots -.
| Scale | Pre-test M(SD) | Post-test M(SD) | Degree of freedom ( | t value ( | p value ( |
|---|---|---|---|---|---|
| Diabetes Knowledge Questions | 5.83 (2.17) | 7.03 (2.24) | 29 | 4.466 | .000** |
| Diabetes Self-Care Behavioral Confidence | 7.55 (1.56) | 7.96 (1.78) | 29 | 1.403 | .171 |
| Application feasibility | 14.10 (3.9) | 16.13 (3.48) | 29 | 3.287 | .003* |
| Increase health knowledge of the disease | 3.43 (1.01) 1–5 | 4.1 (.80) 2–5 | 29 | 3.673 | .001* |
| Help with disease management | 3.63 (.85) 1–5 | 4.00 (1.02) 1–5 | 29 | 1.884 | .070 |
| Reduce anxiety about the disease | 3.47 (1.04) 1–5 | 4.07 (.91) 1–5 | 29 | 3.168 | .004* |
| Facilitate interaction with pharmacists in community pharmacies | 3.57 (1.01) 1–5 | 3.97 (1.00) 1–5 | 29 | 2.350 | .026 |
a * p < 0.05
b **< 0.001
c Total score of 10 for the question on diabetes knowledge; average score for confidence in diabetes self-care behaviors; total score of 20 for feasibility of use of the application
d strongly agree = 5, agree = 4, no opinion = 3, disagree = 2, strongly disagree = 1.
Correlation analysis between the pretest-posttest and participant characteristics -.
| Gender | Age | Education Level | Diabetes history | Internet experience | Mobile application experience | Robotics experience | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male (n = 15) | Female (n = 15) | p | 45–64 years old (n = 8) | 65+ years old (n = 22) | p | Below junior high school (n = 13) | High school and above (n = 17) | p | Less than 10 years (n = 15) | More than 10 years (n = 15) | p | N/A (n = 15) | Yes (n = 15) | p | No (n = 13) | Yes (n = 17) | p | No contact experience (n = 12) | Had contact (n = 18) | p | |
|
| |||||||||||||||||||||
| Total score | 8.20 (3.23) | 7.80 (3.28) | .320 | 8.50 (3.46) | 7.82 (3.17) | .229 | 7.23 (3.88) | 8.59 (2.55) | .672 | 6.93 (4.15) | 9.07 (1.28) | .674 | 7.60 (3.72) | 8.40 (2.67) | .113 | 7.15 (3.83) | 8.65 (2.57) | .360 | 6.67 (4.12) | 8.89 (2.11) | .109 |
|
| |||||||||||||||||||||
| pre-test 1 | 3.60 (.83) | 3.27 (1.16) | .596 | 3.50 (.93) | 3.41 (1.50) | 1.000 | 3.38 (1.04) | 3.47 (1.01) | .876 | 3.33 (1.29) | 3.53 (.64) | .947 | 3.47 (.99) | 3.40 (1.06) | .740 | 3.23 (.93) | 3.59 (1.06) | .305 | 3.08 (1.08) | 3.67 (.91) | .087 |
| pre-test 2 | 3.80 (.68) | 3.47 (.99) | .45 | 4.00 (.76) | 3.50 (.86) | .178 | 3.46 (.78) | 3.76 (.903) | .152 | 3.67 (1.11) | 3.60 (.51) | .492 | 3.47 (.64) | 3.80 (1.01) | .137 | 3.46 (.66) | 3.76 (.97) | .196 | 3.50 (.80) | 3.72 (.90) | .293 |
| pre-test 3 | 3.73 (1.03) | 3.20 (1.01) | .12 | 4.00 (.756) | 3.27 (1.08) | .092 | 3.08 (.95) | 3.76 (1.03) | .024* | 3.40 (1.30) | 3.53 (.74) | 1.000 | 3.33 (.976) | 3.6 (1.121) | .405 | 3.23 (.927) | 3.65 (1.115) | .251 | 3.50 (.798) | 3.44 (1.199) | .858 |
| pre-test 4 | 3.73 (1.03) | 3.40 (.99) | .306 | 4.00 (.76) | 3.41 (1.05) | .175 | 3.31 (1.03) | 3.76 (.97) | .164 | 3.47 (1.30) | 3.67 (.62) | 1.000 | 3.47 (.99) | 3.67 (1.05) | .609 | 3.31 (.95) | 3.76 (1.03) | .201 | 3.50 (.80) | 3.61 (1.15) | .440 |
| post-test 1 | 4.20 (.78) | 4.00 (.85) | .545 | 4.25 (1.04) | 4.05 (.72) | .323 | 3.92 (.76) | 4.24 (.83) | .206 | 4.07 (1.03) | 4.13 (.52) | .875 | 4.07 (.80) | 4.13 (.83) | .720 | 3.92 (.76) | 4.24 (.83) | .206 | 3.83 (1.03) | 4.28 (.58) | .226 |
| post-test 2 | 4.20 (.78) | 3.80 (1.21) | .461 | 4.13 (1.36) | 3.95 (.90) | .324 | 3.69 (1.03) | 4.24 (.83) | .091 | 3.87 (1.36) | 4.13 (.52) | .911 | 3.87 (1.06) | 4.13 (.99) | .434 | 3.77 (1.01) | 4.18 (1.02) | .191 | 3.67 (1.37) | 4.22 (.65) | .386 |
| post-test 3 | 4.20 (.78) | 3.93 (1.03) | .545 | 4.13 (1.36) | 4.05 (.72) | .323 | 4.00 (.82) | 4.12 (.99) | .470 | 4.07 (1.16) | 4.07 (.59) | .560 | 4.07 (.80) | 4.07 (1.03) | .720 | 4.00 (.71) | 4.12 (1.05) | .406 | 4.08 (1.17) | 4.06 (.73) | .522 |
| post-test 4 | 4.27 (.70) | 3.67 (1.18) | .147 | 4.13 (1.36) | 3.91 (.87) | .264 | 3.92 (.86) | 4.00 (1.12) | .535 | 3.87 (1.30) | 4.07 (.59) | 1.000 | 3.93 (.84) | 4.00 (1.13) | .539 | 3.77 (.83) | 4.12 (1.11) | .132 | 3.92 (1.24) | 4.00 (.84) | .911 |
|
| |||||||||||||||||||||
| Pre-post Differences | 1.07 (1.49) | 1.33 (1.50) | .579 | .50 (.76) | 1.45 (1.60) | .117 | .92 (1.60) | 1.41 (1.37) | .291 | .93 (1.33) | 1.47 (1.60) | .326 | 1.07 (1.67) | 1.33 (1.29) | .468 | .77 (1.36) | 1.53 (1.51) | .168 | 1.17 (1.59) | 1.22 (1.44) | .711 |
|
| |||||||||||||||||||||
| Pre-post Difference | 1.03 (1.56) | -.21 (1.41) | .072 | 1.22 (1.22) | .11 (1.45) | .320 | -.077 (1.82) | .78 (1.33) | .411 | .33 (2.07) | .49 (.97) | .915 | .04 (1.75) | .78 (1.38) | .577 | -.0769 | .77 (1.53) | .745 | .02 (1.95 | .67 (1.30) | .844 |
a N(SD)
b * p<0.05
c Note for question number.
Interaction with the community pharmacy robot can help me increase my knowledge of health-related illnesses.
The community pharmacy robot can help me with disease management.
Community pharmacy robots can help me reduce my anxiety related to my illness.
Community pharmacy robots can help facilitate my interactions with community pharmacists.
d total score of 20 for feasibility of application (strongly agree = 5, agree = 4, no opinion = 3, disagree = 2, strongly disagree = 1).